Cancer Screen Test

Answering questions like "how many genetically transformed (with gene mutations associated with becoming cancerous) cells does it take to form a detectable tumour?" and "how frequently do such screen-obvious tumours transition to become clinically apparent and symptomatic" is of great importance to establish the benefits or risks of cancer screening. Here, in a breast cancer mouse model, researchers track the early cell to screen-detectable lesion and then the next stage to becoming lethal cancer. They reveal that the step from genetically transformed to screen-detectable lesion is rare, and that spread doesn't necessarily correlate with growth rate

Read the published research article here

Written by Lindsey Goff

Lindsey Goff

Editor-in-Chief

Formerly immunologist for Cancer Research UK, Lindsey has since moved into the field of scientific publishing. She looks after all BPoD editorial matters.

• Image from work by Joshua D. Ginzel and colleagues
• Department of Surgery, Duke University, Durham, NC, USA
• Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)
• Published in Disease Models & Mechanisms, March 2025